BrainStorm Cell Therapeutics
BCLI
#10915
Rank
ยฃ7.94 M
Marketcap
ยฃ0.72
Share price
-4.04%
Change (1 day)
39.42%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -ยฃ7.89 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ7.82 Million, an increase over its 2024 earnings that were of -ยฃ8.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ7.89 Million0.94%
2025 -ยฃ7.82 Million-11.32%
2024 -ยฃ8.82 Million-32.39%
2023 -ยฃ13.04 Million-29.18%
2022 -ยฃ18.41 Million-0.74%
2021 -ยฃ18.55 Million-23.12%
2020 -ยฃ24.13 Million36.8%
2019 -ยฃ17.64 Million66.71%
2018 -ยฃ10.58 Million181.66%
2017 -ยฃ3.76 Million-0.6%
2016 -ยฃ3.78 Million-41.31%
2015 -ยฃ6.44 Million-8.22%
2014 -ยฃ7.02 Million89.74%
2013 -ยฃ3.7 Million42.27%
2012 -ยฃ2.6 Million-12.45%
2011 -ยฃ2.97 Million63.04%
2010 -ยฃ1.82 Million35.52%
2009 -ยฃ1.35 Million-48.99%
2008 -ยฃ2.64 Million-44.39%
2007 -ยฃ4.74 Million
2005 -ยฃ2.46 Million-91.44%
2004 -ยฃ28.65 Million94007.62%
2003 -ยฃ0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
ยฃ0.33 B-4,330.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ1.93 Billion 23,973.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-ยฃ0.6 Billion 7,413.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ0.59 Billion 7,293.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ0.11 B-1,535.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-ยฃ0.2 Billion 2,328.14%๐Ÿ‡บ๐Ÿ‡ธ USA